Notably, many studies have already demonstrated that MEK/ERK signaling pathways could control ETS-1 expression and activity through ERK phosphorylation of ETS-1 at Threonine 38 in many types of cancers [10–14]. This evidence concerns the gene ETS1 and cancer.